Inventor
COLLINS MARY
US42 patents
⚠️ This page may combine multiple inventors who share the name “COLLINS MARY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENETICS INST
8 patentsUS5710023AJan 20, 1998
IL-13 cytokine receptor chain
GENETICS INST131 citations98
US4725536AFeb 16, 1988
Reagent polynucleotide complex with multiple target binding regions, and kit and methods
GENETICS INST274 citations98
US4752566AJun 21, 1988
Displacement polynucleotide method and reagent complex employing labeled probe polynucleotide
GENETICS INST69 citations96
US6214559B1Apr 10, 2001
Methods of identifying inhibitors of binding of IL-13 to the IL-13 receptor chain
GENETICS INST32 citations95
US6268480B1Jul 31, 2001
IL-13 Receptor chain
GENETICS INST23 citations92
US6248714B1Jun 19, 2001
Methods of inhibiting binding and treating Ig-mediated responses with IL-13 receptor
GENETICS INST25 citations92
US6022714AFeb 8, 2000
Methods for attachment of a polynucleotide to a preselected material
GENETICS INST20 citations92
US5268266ADec 7, 1993
Process and nucleic acid construct for producing reagent complexes useful in determining target nucleotide sequences
GENETICS INST25 citations92
GENETICS INST LLC
8 patentsUS7078494B1Jul 18, 2006
Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
GENETICS INST LLC43 citations92
US7553487B2Jun 30, 2009
Method and compositions for treating asthma
GENETICS INST LLC36 citations91
US7189400B2Mar 13, 2007
Methods of treatment with antagonists of MU-1
GENETICS INST LLC20 citations89
US7198789B2Apr 3, 2007
Methods and compositions for modulating interleukin-21 receptor activity
GENETICS INST LLC32 citations87
US7674591B2Mar 9, 2010
Methods of using antibodies to human IL-13bc for inhibiting IL-13 binding
GENETICS INST LLC8 citations83
US7507706B1Mar 24, 2009
Cytokine receptor chain
GENETICS INST LLC7 citations72
US7666421B2Feb 23, 2010
Methods of treatment of autoimmune diseases using humanized immunoglobulin reactive with B7-2
GENETICS INST LLC0 citations51
US7531175B2May 12, 2009
Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules
GENETICS INST LLC1 citations51
INST GENETICS LLC
5 patentsUS6913747B1Jul 5, 2005
Humanized immunoglobulin reactive with B7 therewith
INST GENETICS LLC80 citations98
US6984383B1Jan 10, 2006
Method of transplanting cells by contacting donor cells with B7-1-and B7-2-specific immunoglobulins
INST GENETICS LLC57 citations95
US6664227B1Dec 16, 2003
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
INST GENETICS LLC61 citations94
US6827934B1Dec 7, 2004
Humanized immunoglobulin reactive with b7-2 and methods of treatment therewith
INST GENETICS LLC17 citations92
US6972125B2Dec 6, 2005
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
INST GENETICS LLC8 citations73
WYETH CORP
4 patentsUS7488802B2Feb 10, 2009
Antibodies against PD-1
WYETH CORP1,122 citations97
US7618632B2Nov 17, 2009
Method of treating or ameliorating an immune cell associated pathology using GITR ligand antibodies
WYETH CORP326 citations92
US7495085B2Feb 24, 2009
Antibodies against human or mouse IL-21 receptor
WYETH CORP26 citations90
US7314623B2Jan 1, 2008
Methods and compositions for modulating T helper (Th) cell development and function
WYETH CORP32 citations89